CSIMarket Company Name, Ticker, Competitors, else..
 
Avita Medical Inc   (NASDAQ: RCEL)
Other Ticker:  
 
 

RCEL's Market share relative to its competitors, as of Q4 2024

As of Q4 2024 (Revenue in Millions of $)

Date modified: 2025-05-07T14:06:21+00:00




 
COMPANY NAME REVENUES
12 Months Ending
Q4 2024		 MARKET SHARE
12 Months
Q4 2024		 MARKET SHARE
MRQ
Q4 2024		 MARKET SHARE
A Quarter Before
Q3 2024
Avita Medical Inc 64.25 0.10% 0.11 % 0.15 %
3m Company 24,513.00 38.02% 35.50% 47.54%
Stryker Corp 18,449.00 28.62% 31.02% 35.43%
Baxter International Inc 9,669.00 15.00% 15.65% 4.22%
Smith and Nephew Plc 5,549.00 8.61% 8.61% 0.00%
Icu Medical Inc 2,382.05 3.69% 3.76% 4.66%
Integra Lifesciences Holdings Corp 1,624.31 2.52% 2.28% 3.50%
Organogenesis Holdings Inc 482.04 0.75% 0.76% 0.91%
Inmode Ltd 394.82 0.61% 0.61% 0.00%
Mimedx Group Inc 352.73 0.55% 0.52% 0.75%
Anika Therapeutics Inc 165.85 0.26% 0.28% 0.30%
Establishment Labs Holdings Inc 165.53 0.26% 0.27% 0.31%
Cutera Inc 154.20 0.24% 0.19% 0.27%
Sientra Inc 89.27 0.14% 0.11% 0.18%
Sanara Medtech Inc 86.53 0.13% 0.17% 0.16%
Tela Bio Inc 68.49 0.11% 0.11% 0.15%
Pro dex Inc 64.12 0.10% 0.10% 0.13%
Venus Concept Inc 50.31 0.08% 0.08% 0.09%
Apyx Medical Corp 47.36 0.07% 0.09% 0.09%
Koru Medical Systems Inc 33.65 0.05% 0.05% 0.06%
Strata Skin Sciences Inc 31.95 0.05% 0.05% 0.06%
Nuwellis Inc 8.12 0.01% 0.01% 0.02%
Nexgel Inc 7.75 0.01% 0.02% 0.02%
Pavmed Inc 3.25 0.01% 0.00% 0.01%
Pulse Biosciences Inc 2.76 0.00% 0.00% 0.00%
Nanovibronix Inc 2.51 0.00% 0.00% 0.00%
Vycor Medical Inc 1.44 0.00% 0.00% 0.00%
Nuo Therapeutics Inc 1.37 0.00% 0.00% 0.00%
Femasys Inc 1.26 0.00% 0.00% 0.00%
Lyra Therapeutics Inc 1.19 0.00% 0.00% 0.00%
Arch Therapeutics Inc 0.15 0.00% 0.00% 0.00%
Envveno Medical Corporation 0.00 0.00% 0.00% 0.00%
SUBTOTAL 64,467.23 100% 16,771.40 100%



RCEL's Market share relative to its competitors, as of Q4 2024 within the Medical Equipment & Supplies Industry
As of Q4 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
12 Months Ending
Q3 2024		 MARKET SHARE
MRQ
Q4 2024		 MARKET SHARE

Q3 2024
Avita Medical Inc 0.10% 0.10% 0.11 % 0.16 %
3m Company 38.31% 43.56% 35.77% 47.98%
Stryker Corp 28.83% 29.44% 31.25% 35.75%
Baxter International Inc 15.11% 17.44% 15.77% 4.25%
Smith and Nephew Plc 8.67% 0.00% 8.67% 0.00%
Icu Medical Inc 3.72% 3.84% 3.79% 4.70%
Integra Lifesciences Holdings Corp 2.54% 2.64% 2.30% 3.53%
Inmode Ltd 0.62% 0.81% 0.62% 0.81%
Mimedx Group Inc 0.55% 0.57% 0.53% 0.76%
Anika Therapeutics Inc 0.26% 0.27% 0.28% 0.31%
Establishment Labs Holdings Inc 0.26% 0.25% 0.27% 0.32%
Cutera Inc 0.24% 0.28% 0.19% 0.27%
Sientra Inc 0.14% 0.15% 0.11% 0.18%
Sanara Medtech Inc 0.14% 0.13% 0.17% 0.17%
Tela Bio Inc 0.11% 0.11% 0.11% 0.15%
Pro dex Inc 0.10% 0.10% 0.10% 0.13%
Venus Concept Inc 0.08% 0.09% 0.08% 0.09%
Apyx Medical Corp 0.07% 0.08% 0.09% 0.09%
Koru Medical Systems Inc 0.05% 0.05% 0.05% 0.07%
Strata Skin Sciences Inc 0.05% 0.05% 0.05% 0.06%
Nuwellis Inc 0.01% 0.01% 0.01% 0.02%
Nexgel Inc 0.01% 0.01% 0.02% 0.02%
Pavmed Inc 0.01% 0.01% 0.00% 0.01%
Pulse Biosciences Inc 0.00% 0.00% 0.00% 0.00%
Nanovibronix Inc 0.00% 0.00% 0.00% 0.00%
Vycor Medical Inc 0.00% 0.00% 0.00% 0.00%
Nuo Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Femasys Inc 0.00% 0.00% 0.00% 0.00%
Lyra Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Arch Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Envveno Medical Corporation 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



RCEL's Market share relative to its competitors, as of Q4 2024 within the Healthcare Sector
As of Q4 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
12 Months Ending
Q3 2024		 MARKET SHARE
MRQ
Q4 2024		 MARKET SHARE

Q3 2024
Avita Medical Inc 0.10% 0.10% 0.11 % 0.15 %
3m Company 38.02% 43.24% 35.50% 47.54%
Stryker Corp 28.62% 29.22% 31.02% 35.43%
Baxter International Inc 15.00% 17.31% 15.65% 4.22%
Smith and Nephew Plc 8.61% 0.00% 8.61% 0.00%
Icu Medical Inc 3.69% 3.81% 3.76% 4.66%
Integra Lifesciences Holdings Corp 2.52% 2.62% 2.28% 3.50%
Organogenesis Holdings Inc 0.75% 0.74% 0.76% 0.91%
Inmode Ltd 0.61% 0.80% 0.61% 0.80%
Mimedx Group Inc 0.55% 0.57% 0.52% 0.75%
Anika Therapeutics Inc 0.26% 0.26% 0.28% 0.30%
Establishment Labs Holdings Inc 0.26% 0.25% 0.27% 0.31%
Cutera Inc 0.24% 0.27% 0.19% 0.27%
Sientra Inc 0.14% 0.15% 0.11% 0.18%
Sanara Medtech Inc 0.13% 0.12% 0.17% 0.16%
Tela Bio Inc 0.11% 0.11% 0.11% 0.15%
Pro dex Inc 0.10% 0.10% 0.10% 0.13%
Venus Concept Inc 0.08% 0.08% 0.08% 0.09%
Apyx Medical Corp 0.07% 0.08% 0.09% 0.09%
Koru Medical Systems Inc 0.05% 0.05% 0.05% 0.06%
Strata Skin Sciences Inc 0.05% 0.05% 0.05% 0.06%
Nuwellis Inc 0.01% 0.01% 0.01% 0.02%
Nexgel Inc 0.01% 0.01% 0.02% 0.02%
Pavmed Inc 0.01% 0.01% 0.00% 0.01%
Pulse Biosciences Inc 0.00% 0.00% 0.00% 0.00%
Nanovibronix Inc 0.00% 0.00% 0.00% 0.00%
Vycor Medical Inc 0.00% 0.00% 0.00% 0.00%
Nuo Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Femasys Inc 0.00% 0.00% 0.00% 0.00%
Lyra Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Arch Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Envveno Medical Corporation 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Avita Medical Inc's market divisions, geographic dispersion, segments, products, and services, visit Avita Medical Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com